In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
There was a stampede in the Sangam area of Prayagraj on Tuesday night. Many people were inj
Prayers were offered for peace and prosperity in the country on Bakrid at the Taj Mahal. Morning
Chief Minister Yogi Adityanath inaugurated the construction work of the divine sanctum sanctorum
Kangana Ranaut again taunted Karan Johar said- Your Hindi has improved now, see what happens next
The war between Kangana Ranaut and Karan Johar has intensified. After the reply from the filmmake
Hisar Airport or Rajkot Greenfield International Airport is going to be operational from August t
Lunar Eclipse 2023: The first lunar eclipse of the year 2023 is falling on 5 May. This shadow wil
'The whole world has expectations from India', PM Modi said at MP Global Investors Summit.
PM Modi inaugurated the Global Investors Summit in Bhopal today. This summit will run from 24-25
In view of the Bihar elections, the opposition parties have opened a front against the Election C
Corona has become deadly again in Punjab. A corona patient died in Mansa. At the same time, in Fa
Former Chief Minister Trivendra Singh Rawat, who arrived on Monday to visit Shri Kedarnath Dham i
